Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Risperidone and cognitive function in children with disruptive behavior disorders.

Pandina GJ, Bilder R, Harvey PD, Keefe RS, Aman MG, Gharabawi G.

Biol Psychiatry. 2007 Aug 1;62(3):226-34. Epub 2007 Jan 8.

PMID:
17210137
2.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
3.

Efficacy of risperidone in children with disruptive behavioural disorders.

Duhig MJ, Saha S, Scott JG.

J Paediatr Child Health. 2013 Jan;49(1):19-26. doi: 10.1111/j.1440-1754.2011.02200.x. Epub 2011 Nov 3. Review.

PMID:
22050179
4.

Risperidone in the management of agitation and aggression associated with psychiatric disorders.

De Deyn PP, Buitelaar J.

Eur Psychiatry. 2006 Jan;21(1):21-8. Epub 2006 Jan 18. Review.

PMID:
16414250
5.
6.

Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.

Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP.

J Clin Psychiatry. 2009 Jan;70(1):104-12. Epub 2008 Nov 18. Review.

PMID:
19026265
7.

Risperidone in the management of disruptive behavior disorders.

Pandina GJ, Aman MG, Findling RL.

J Child Adolesc Psychopharmacol. 2006 Aug;16(4):379-92. Review.

PMID:
16958564
8.

Role of risperidone in children with autism spectrum disorder.

Chavez B, Chavez-Brown M, Rey JA.

Ann Pharmacother. 2006 May;40(5):909-16. Epub 2006 Mar 7. Review.

PMID:
16684811
9.
10.

Review of antipsychotics in children and adolescents.

Kapetanovic S, Simpson GM.

Expert Opin Pharmacother. 2006 Oct;7(14):1871-85. Review. Erratum in: Expert Opin Pharmacother. 2007 Apr;8(5):723.

PMID:
17020414
11.

Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents.

Ipser J, Stein DJ.

Psychopharmacology (Berl). 2007 Mar;191(1):127-40. Epub 2006 Sep 16. Review.

PMID:
16983542
12.

Fasting and cognitive function.

Pollitt E, Lewis NL, Garza C, Shulman RJ.

J Psychiatr Res. 1982-1983;17(2):169-74. Review.

PMID:
6764933
13.

Psychopharmacology of conduct disorder: current progress and future directions.

Tcheremissine OV, Cherek DR, Lane SD.

Expert Opin Pharmacother. 2004 May;5(5):1109-16. Review.

PMID:
15155112
14.

Management of disruptive behavior disorders.

French WP, Kisicki MD.

Pediatr Ann. 2011 Nov;40(11):563-8. doi: 10.3928/00904481-20111007-07. Review. No abstract available.

PMID:
22066508
15.

Drugs, learning and cognitive function in children--an update.

Werry JS.

J Child Psychol Psychiatry. 1988 Mar;29(2):129-41. Review. No abstract available.

PMID:
2897374
16.
17.

Treating Disruptive Behavior Disorders in Children and Teens: A Review of the Research for Parents and Caregivers.

John M. Eisenberg Center for Clinical Decisions and Communications Science.

Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005-.
2016 Aug 31.

Supplemental Content

Support Center